跳到正文
cccskills
免费在 GitHub 公开

es-cushing-screening-tests-for-hypercortisolism-recurrence

This skill recommends using biochemical tests to screen for hypercortisolism to detect recurrence in patients with ACTH-dependent Cushing's syndrome after surgical remission. It is triggered during postoperative follow-up when the HPA axis has recovered, annually, or sooner if clinical signs of hypercortisolism (e.g., weight gain, hypertension, glucose intolerance) or abnormal late-night salivary cortisol/UFC appear.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL
查看安装方法

包含的文件（1）

  • SKILL.md3.1 KB

SKILL.md（原文）

安装前可以查看交给 AI 代理的指令内容。

Using Tests to Screen for Hypercortisolism to Assess for Recurrence in ACTH-Dependent Cushing's Syndrome

STEP 1 — Gather Information

Collect postoperative timing, HPA axis recovery status, symptoms (weight gain, hypertension, glucose intolerance, fatigue, mood changes), prior biochemical remission values, and imaging if available. Obtain late-night salivary cortisol, urine free cortisol (UFC), or low-dose dexamethasone suppression test per local protocol.

STEP 2 — Rule In / Rule Out

Is there a clinical suspicion of recurrence (new/significant symptoms) OR an abnormal screening test (late-night salivary cortisol > upper limit of normal, UFC > 2× ULN, or failure to suppress cortisol with dexamethasone)?

  • Yes: Proceed to confirmatory testing.
  • No: Continue routine surveillance (clinical assessment annually and biochemical testing every 6–12 months).

STEP 3 — Classify or Stratify

If screening test is abnormal, repeat the same test under standardized conditions (avoid stress, illness, medication interference).

  • Repeat normal: Consider false positive; maintain routine surveillance.
  • Repeat abnormal: Proceed to definitive evaluation (pituitary MRI, petrosal sinus sampling if ACTH-dependent source uncertain, or adrenal imaging if adrenal source suspected).

STEP 4 — Decide

If imaging confirms a lesion suggestive of recurrent ACTH source: discuss repeat transsphenoidal surgery, radiation therapy, medical therapy, or bilateral adrenalectomy based on lesion resectability, patient preference, and comorbidities.
If no lesion identified but biochemical evidence persists: consider empirical medical therapy (steroidogenesis inhibitor) or repeat imaging in 3–6 months.

Clinical Guardrails / Mimics / Pitfalls

Do not diagnose recurrence on a single abnormal test without confirmation due to assay variability, stress, or medication effects. Avoid overtreatment of borderline results; ensure HPA axis has recovered before interpreting cortisol levels. Do not neglect subtle symptoms (e.g., mild weight gain) as they may precede biochemical relapse.

Concrete Clinical Example

A 42‑year‑old woman with ACTH‑dependent Cushing’s disease underwent transsphenoidal surgery; 14 months postoperatively she reported 5 kg weight gain and new‑onset hypertension. Late‑night salivary cortisol was 1.8× ULN; repeat test remained elevated. Pituitary MRI showed a 6 mm enhancing lesion. She opted for repeat transsphenoidal surgery, achieving postoperative UFC < ULN and symptom resolution.

Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., 2015, DOI: 10.1210/jc.2015-1818

评价

还没有评价。欢迎分享你的使用感受。

评论

无需登录即可发表。欢迎分享使用感受、提问，或说明在哪些环境下无法运行。

还没有评论。来写第一条吧。

提交后会立即公开。请勿填写邮箱、电话等个人信息。URL 最多 2 个。

0 / 1000 字

此表单受 reCAPTCHA 保护，适用 Google 的隐私权政策和服务条款。

同一仓库的技能

780g-pump-adjustment

免费

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-acth-stim-test-interpretation

免费

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-adrenal-crisis-treatment

免费

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-aed-ai-education

免费

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-aed-lt4-monitoring

免费

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

ata-cortisol-cutoff-ai-diagnosis

免费

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

查看 dromlakhani 的全部技能

报告此技能的问题